Avandia, a Case of Deja Vu all over again
Even worse, FDA officials, in collusion and collaboration with GSK, approved an unethical and exploitative clinical trial—TIDE, which is on-going.
Correspondence: NYS HPV Vaccine Legislation On Hold
Dr. Diane Harper advises AGAINST proposed NYS HPV legislationwithout parental consent.
GMC Damning Wakefield Verdict Does Not Address Autism-Vaccine Validity
Given multiple prior investigations of Dr. Wakefied’s 1998 paper, why did it take the Lancet editors 12 years to discover a lack of proper IRB approval?
Eli Lilly Exec Heads to Harvard Medical School
"Does this appointment signify that Harvard Medical School intends to even further strengthen its research ties to the pharmaceutical industry?"
DSM5 Revisions
"Anything you put in that book, any little change you make, has huge implications not only for psychiatry but for pharmaceutical marketing, research, for the legal system, for who’s considered to be normal or not, for who’s considered disabled," said Dr. Michael First, professor of psychiatry at Columbia University who edited the DSM4l but is not involved in the DSM5.
Criminal Drug Marketing Remains an Issue
In December, 2009, Bloomberg News published an investigative report by David Evans reported, "Big Pharma’s Crime Spree" documenting major court settlements: "Pfizer, Eli Lilly & Co., Bristol-Myers Squibb Co. and four other drug companies have paid a total of $7 billion in fines and penalties. Six of the companies…
Unethical US Gov Blood Experiment vs. Canadian Version
The Alliance for Human Research Protection (AHRP) has recently obtained further information reaffirming our original concerns and raising new ones about the safety and ethics of a government sponsored clinical trial.
An Ethically Dubious Blood Experiment: RECESS
AHRP is concerned about the ethics and safety of human subjects in a blood storage experiment ( RECESS) sponsored
by the National Heart Lung and Blood Institute.
Antidepressants shown worthless for most consumers
The comments below expand upon an Infomail about the recently published JAMA meta-analysis.
JAMA Antidepressant Meta-analysis Reveals 22 Years of Deception
Twenty-two years after the US marketing of Prozac, JAMA meta-analysis shows antidepressants to be worthless for most of the people for whom they are prescribed.
FDA May Relassify ECT devices
Last Chance to Send Comments RE: Proposed Reclassification of ECTdevices
America’s Poor Children Likelier to Get Antipsychotics_NYT
A front page article in The New York Times raises the long-overdue alarms about the forced drugging of American children–in particular poor children who are condemned to ingest toxic neuroleptics (a.k.a. ‘atypical antipsychotics) at a rate four times higher than children whose parents have private insurance. These drugs qualify under…